Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.40 |
| ▸ | CNR2 | P34972 | 3/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | P2RY10 | O00398 | 3/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.32 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9229451 | 0.90 | EPHX2 (0.41) | EPHX2CNR2P2RY10CNR1ALDH1A1 | |
| SCHEMBL13030430 | 0.90 | EPHX2 (0.41) | EPHX2CNR2P2RY10CNR1ALDH1A1 | |
| SCHEMBL78014 | 0.90 | EPHX2 (0.41) | EPHX2CNR2P2RY10CNR1ALDH1A1 | |
| SCHEMBL6863921 | 0.89 | EPHX2 (0.39) | EPHX2CNR2P2RY10CNR1ALDH1A1 | |
| SCHEMBL6471445 | 0.88 | EPHX2 (0.36) | EPHX2CNR2ALOX5P2RY10CNR1 | |
| SCHEMBL9870753 | 0.87 | CNR1 (0.40) | EPHX2CNR1ALDH1A1KDM4E | |
| SCHEMBL7521604 | 0.87 | KDM4E (0.42) | ALDH1A1KDM4EHPGD | |
| SCHEMBL22915501 | 0.87 | EPHX2 (0.38) | EPHX2CNR2P2RY10CNR1 | |
| SCHEMBL12919745 | 0.84 | EPHX2 (0.41) | EPHX2ALOX5P2RY10CNR1ALDH1A1 | |
| SCHEMBL23533531 | 0.84 | CNR2 (0.41) | EPHX2CNR2ALOX5P2RY10CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6489383-B1 | SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-12-03 | — | — | US | disclosed |
| US-20020169239-A1 | 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith | WOOD MERVIN G (US) | 2002-11-14 | — | — | US | disclosed |
| US-6392056-B1 | FOR THERMOPLASTIC RESINS | CIBA SPECIALTY CHEMICAL CORPORATION | 2002-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020169239-A1 | 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith | SUV39H1, SUV39H2, PAH | EPHX2 1869/4885CNR2 3089/4885ALOX5 2975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.